Albumin-Bound Paclitaxel /nab-Paclitaxel

DRUG3 trials

Sponsors

National Health Research Institutes, Taiwan, Eye & ENT Hospital of Fudan University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions

Biliary CancersFallopian Tube CancersGastric Cancer in SituHigh-grade Serous Ovarian Cancer (HGSOC)Hypopharyngeal CarcinomaPancreatic CancersPrimary Peritoneal Cancer

Phase 1

Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers

CompletedNCT03162510

National Health Research Institutes, TaiwanBiliary Cancers, Gastric Cancer in Situ, Pancreatic Cancers

Start: 2018-06-26End: 2022-01-31Updated: 2022-04-07

Phase 2

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

RecruitingNCT07248956

Eye & ENT Hospital of Fudan UniversityHypopharyngeal Carcinoma

Start: 2025-12-22End: 2029-12-30Target: 116Updated: 2025-12-23

Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer

Not yet recruitingNCT07432594

Cancer Institute and Hospital, Chinese Academy of Medical SciencesFallopian Tube Cancers, High-grade Serous Ovarian Cancer (HGSOC), Primary Peritoneal Cancer

Start: 2026-03-01End: 2027-06-30Target: 82Updated: 2026-02-25

Related Papers

A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study

The Oncologist2024-06-21